flgf4 -
from one of several extremely pertinent and fascinating Barton Haynes recently published patent applications:
WHAT IS CLAIMED IS:
1. A method of treating HIV comprising administering to a patient in need thereof an antibody derivable from a normal subject or from an
autoimmune disease subject that binds to a lipid on the surface of HIV or on the surface of HIV-infected cells and thereby neutralizes HIV-
1, wherein said antibody is administered in an amount sufficient to effect said treatment.
2. The method according to claim 1 wherein said antibody is derivable from an anti-phospholipid syndrome subject.
3. The method according to claim 1 wherein said antibody is non-pathogenic.
4. The method according to claim 1 wherein said antibody is IS1, IS4 or IS6, or binding fragment thereof.
5. The method according to claim 1 wherein said antibody is IS1, or binding fragment thereof.
[0105] ....That IS1 neutralized HIV evidences the facts that: a) humans can make non-pathogenic anti-lipid antibodies that neutralize HIV,
and b) IS1 is an antibody that can be safely used as a therapeutic Mab for treatment of HIV infected subjects or in the setting of postexposure
prophylaxis
---------
j